---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-004450"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T00:38:48.048531+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# KemPharm changes name to Zevra Therapeutics; ticker to become ZVRA on March 1, 2023

## Summary
- Name change effective February 21, 2023 via Delaware certificate of amendment.
- Common stock ticker to change from KMPH to ZVRA on Nasdaq on or about March 1, 2023.
- No shareholder vote required; rights of shareholders, creditors, and CUSIP unchanged.
- Bylaws amended and restated to reflect new name; no other charter or bylaw changes.

## SEC filing metadata
- accession: 0001437749-23-004450
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/kmph20230220_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-004450
- JSON: https://secwatch.observer/filing/0001437749-23-004450.json
- Plain text: https://secwatch.observer/filing/0001437749-23-004450.txt

## Key facts
- Governance Changes
  ZEVRA THERAPEUTICS, INC.: Amended and restated bylaws to reflect name change to Zevra Therapeutics, Inc (effective 2023-02-21).
  - Change: bylaw amendment
  - Effective: 2023-02-21
  source text: The Company also amended and restated its amended and restated bylaws (the “Amended and Restated Bylaws”) effective on February 21, 2023, to reflect the Name Change.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm
- Governance Changes
  ZEVRA THERAPEUTICS, INC.: Changed corporate name to Zevra Therapeutics, Inc. via certificate of amendment to certificate of incorporation (effective 2023-02-21).
  - Change: charter amendment
  - Effective: 2023-02-21
  source text: Effective February 21, 2023, KemPharm, Inc. (the “Company”) changed its corporate name to Zevra Therapeutics, Inc. (the “Name Change”) pursuant to a certificate of amendment to the Company’s certificate of incorporation (the “Charter Amendment”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.